Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 1448-1451, April 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okamoto, A.
Right arrow Articles by Harris, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okamoto, A.
Right arrow Articles by Harris, C. C.

Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 Genes in Primary and Metastatic Lung Cancer1

Aikou Okamoto, S. Perwez Hussain, Koichi Hagiwara, Elisa A. Spillare, Marek R. Rusin, Douglas J. Demetrick, Manuel Serrano, Gregory J. Hannon, Masayuki Shiseki, Maimoona Zariwala, Yue Xiong, David H. Beach, Jun Yokota and Curtis C. Harris2

Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [A. O., S. P. H., K. H., E. A. S., M. R. R., C. C. H.]; Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 [D. J. D., M. S., G. J. H., D. H. B.]; National Cancer Center Research Institute, 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104, Japan [M. S., J. Y.]; and The University of North Carolina, Chapel Hill, North Carolina 27599-3280 [M. Z., Y. X.]

We examined the genomic status of cyclin-dependent kinase-4 and -6 inhibitors, p16INK4, p15INK4B, and p18, in 40 primary lung cancers and 31 metastatic lung cancers. Alterations of the p16INK4 gene were detected in 6 (2 insertions and 4 homozygous deletions) of 22 metastatic non-small cell lung cancers (NSCLCs; 27%), but none were detected in 25 primary NSCLCs, 15 primary small cell lung cancers (SCLCs), or 9 metastatic SCLCs, indicating that mutation in the p16INK4 gene is a late event in NSCLC carcinogenesis. Although three intragenic mutations of the p15INK4B gene were detected in 25 primary NSCLCs (12%) and five homozygous deletions of the p15INK4B gene were detected in 22 NSCLCs (23%), no genetic alterations of the p15INK4B gene were found in primary and metastatic SCLCs. The p18 gene was wild type in these 71 lung cancers, except 1 metastatic NSCLC which showed loss of heterozygosity. We also examined alterations of these three genes and expression of p16INK4 in 21 human lung cancer cell lines. Alterations of the p16INK4 and p15INK4B genes were detected in 71% of the NSCLC cell lines (n = 14) and 50% of the NSCLC cell lines (n = 14), respectively, but there were none in the 7 SCLC cell lines studied. No p18 mutations were detected in these 21 cell lines. These results indicate that both p16INK4 and p15INK4B gene mutations are associated with tumor progression of a subset of NSCLC, but not of SCLC, and that p15INK4B mutations might also be an early event in the molecular pathogenesis of a subset of NSCLC.

1 This work was supported in part by a grant from the Japanese Overseas Cancer Fellowship of the Foundation for Promotion of Cancer Research (to A. O.).

2 To whom requests for reprints should be addressed, at Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bldg. 37, Room 2C01, Bethesda, MD 20892-4255.

Received 1/12/95. Accepted 2/20/95.




This article has been cited by other articles:


Home page
ThoraxHome page
S Mohamed, K Yasufuku, T Nakajima, K Hiroshima, R Kubo, A Iyoda, S Yoshida, M Suzuki, Y Sekine, K Shibuya, et al.
Analysis of cell cycle-related proteins in mediastinal lymph nodes of patients with N2-NSCLC obtained by EBUS-TBNA: relevance to chemotherapy response
Thorax, July 1, 2008; 63(7): 642 - 647.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Salaun, R. Sesboue, S. Moreno-Swirc, J. Metayer, S. Bota, J. Bourguignon, and L. Thiberville
Molecular Predictive Factors for Progression of High-Grade Preinvasive Bronchial Lesions
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 880 - 886.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Roca, R. M. Kypta, and M. d. M. Vivanco
Loss of p16INK4a results in increased glucocorticoid receptor activity during fibrosarcoma development
PNAS, March 18, 2003; 100(6): 3113 - 3118.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Bai, X.-H. Pei, V. L. Godfrey, and Y. Xiong
Haploinsufficiency of p18INK4c Sensitizes Mice to Carcinogen-Induced Tumorigenesis
Mol. Cell. Biol., February 15, 2003; 23(4): 1269 - 1277.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. A. Nicholson, N. T. Okby, M. A. Khan, J. A. Welsh, M. G. McMenamin, W. D. Travis, J. R. Jett, H. D. Tazelaar, V. Trastek, P. C. Pairolero, et al.
Alterations of p14ARF, p53, and p73 Genes Involved in the E2F-1-mediated Apoptotic Pathways in Non-Small Cell Lung Carcinoma
Cancer Res., July 1, 2001; 61(14): 5636 - 5643.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. I. Shapiro, J. G. Supko, A. Patterson, C. Lynch, J. Lucca, P. F. Zacarola, A. Muzikansky, J. J. Wright, T. J. Lynch Jr., and B. J. Rollins
A Phase II Trial of the Cyclin-dependent Kinase Inhibitor Flavopiridol in Patients with Previously Untreated Stage IV Non-Small Cell Lung Cancer
Clin. Cancer Res., June 1, 2001; 7(6): 1590 - 1599.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. T. Yu, R. G. Foster, and D. C. Dean
Transcriptional Repression by Rb-E2F and Regulation of Anchorage-Independent Survival
Mol. Cell. Biol., May 15, 2001; 21(10): 3325 - 3335.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
D.-H. Kim, H. H. Nelson, J. K. Wiencke, S. Zheng, D. C. Christiani, J. C. Wain, E. J. Mark, and K. T. Kelsey
p16INK4a and Histology-specific Methylation of CpG Islands by Exposure to Tobacco Smoke in Non-Small Cell Lung Cancer
Cancer Res., April 1, 2001; 61(8): 3419 - 3424.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
K. Suzuki, J. Fueyo, V. Krasnykh, P. N. Reynolds, D. T. Curiel, and R. Alemany
A Conditionally Replicative Adenovirus with Enhanced Infectivity Shows Improved Oncolytic Potency
Clin. Cancer Res., January 1, 2001; 7(1): 120 - 126.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
M. Seike, A. Gemma, Y. Hosoya, S. Hemmi, Y. Taniguchi, Y. Fukuda, N. Yamanaka, and S. Kudoh
Increase in the Frequency of p16INK4 Gene Inactivation by Hypermethylation in Lung Cancer during the Process of Metastasis and Its Relation to the Status of p53
Clin. Cancer Res., November 1, 2000; 6(11): 4307 - 4313.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
J. Fuxe, G. Akusjärvi, H. M. Goike, G. Roos, V. P. Collins, and R. F. Pettersson
Adenovirus-mediated Overexpression of p15INK4B Inhibits Human Glioma Cell Growth, Induces Replicative Senescence, and Inhibits Telomerase Activity Similarly to p16INK4A
Cell Growth Differ., July 1, 2000; 11(7): 373 - 384.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. N. ROM, J. G. HAY, T. C. LEE, Y. JIANG, and K.-M. TCHOU-WONG
Molecular and Genetic Aspects of Lung Cancer
Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1355 - 1367.
[Full Text]


Home page
Clin. Cancer Res.Home page
M. Omura-Minamisawa, M. B. Diccianni, A. Batova, R. C. Chang, L. J. Bridgeman, J. Yu, J. Pullen, W. P. Bowman, and A. L. Yu
Universal Inactivation of Both p16 and p15 but not Downstream Components Is an Essential Event in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia
Clin. Cancer Res., April 1, 2000; 6(4): 1219 - 1228.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. M. Fong, Y. Sekido, and J. D. Minna
MOLECULAR PATHOGENESIS OF LUNG CANCER
J. Thorac. Cardiovasc. Surg., December 1, 1999; 118(6): 1136 - 1152.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. I. Shapiro, D. A. Koestner, C. B. Matranga, and B. J. Rollins
Flavopiridol Induces Cell Cycle Arrest and p53-independent Apoptosis in Non-Small Cell Lung Cancer Cell Lines
Clin. Cancer Res., October 1, 1999; 5(10): 2925 - 2938.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. C. Mack, D. R. Gandara, C. Bowen, M. J. Edelman, T. Paglieroni, J. B. Schnier, E. P. Gelmann, and P. H. Gumerlock
RB Status as a Determinant of Response to UCN-01 in Non-Small Cell Lung Carcinoma
Clin. Cancer Res., September 1, 1999; 5(9): 2596 - 2604.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Kohno and J. Yokota1
How many tumor suppressor genes are involved in human lung carcinogenesis?
Carcinogenesis, August 1, 1999; 20(8): 1403 - 1410.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Bissig, J. Richter, R. Desper, V. Meier, P. Schraml, A. A. Schaffer, G. Sauter, M. J. Mihatsch, and H. Moch
Evaluation of the Clonal Relationship between Primary and Metastatic Renal Cell Carcinoma by Comparative Genomic Hybridization
Am. J. Pathol., July 1, 1999; 155(1): 267 - 274.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Geradts, K. M. Fong, P. V. Zimmerman, R. Maynard, and J. D. Minna
Correlation of Abnormal RB, p16ink4a, and p53 Expression with 3p Loss of Heterozygosity, Other Genetic Abnormalities, and Clinical Features in 103 Primary Non-Small Cell Lung Cancers
Clin. Cancer Res., April 1, 1999; 5(4): 791 - 800.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Brambilla, S. Gazzeri, D. Moro, S. Lantuejoul, S. Veyrenc, and C. Brambilla
Alterations of Rb Pathway (Rb-p16INK4-Cyclin D1) in Preinvasive Bronchial Lesions
Clin. Cancer Res., February 1, 1999; 5(2): 243 - 250.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. P. Xing, Y. Nie, L.-D. Wang, G.-Y. Yang, and C. S. Yang
Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China
Carcinogenesis, January 1, 1999; 20(1): 77 - 84.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. G. Gorgoulis, P. Zacharatos, A. Kotsinas, T. Liloglou, A. Kyroudi, M. Veslemes, A. Rassidakis, T. D. Halazonetis, J. K. Field, and C. Kittas
Alterations of the p16-pRb Pathway and the Chromosome Locus 9p21–22 in Non-Small-Cell Lung Carcinomas : Relationship with p53 and MDM2 Protein Expression
Am. J. Pathol., December 1, 1998; 153(6): 1749 - 1765.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. P. DeMuth, C. M. Jackson, D. A. Weaver, E. L. Crawford, D. S. Durzinsky, S. J. Durham, A. Zaher, E. R. Phillips, S. A. Khuder, and J. C. Willey
The Gene Expression Index c-myc × E2F-1/p21 Is Highly Predictive of Malignant Phenotype in Human Bronchial Epithelial Cells
Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 18 - 24.
[Abstract] [Full Text]


Home page
BloodHome page
M. Pinyol, F. Cobo, S. Bea, P. Jares, I. Nayach, P. L. Fernandez, E. Montserrat, A. Cardesa, and E. Campo
p16INK4a Gene Inactivation by Deletions, Mutations, and Hypermethylation Is Associated With Transformed and Aggressive Variants of Non-Hodgkin's Lymphomas
Blood, April 15, 1998; 91(8): 2977 - 2984.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-W. Tchou, W. N. Rom, and K.-M. Tchou-Wong
Novel Form of p21WAF1/CIP1/SDI1 Protein in Phorbol Ester-induced G2/M Arrest
J. Biol. Chem., November 22, 1996; 271(47): 29556 - 29560.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.